valproic acid and medroxyprogesterone acetate

valproic acid has been researched along with medroxyprogesterone acetate in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Andrews, PR; Craik, DJ; Martin, JL1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Bottomley, SS; Bronze, MS; Dhaliwal, G; Jackson, R; Toubia, N1
Bunce, CM; Ellington, MA; Johnson, WE; Khanim, FL; MacKay, HL; Sheard, JJ; Snow, MD; Southam, AD1
Alhazmi, B; Beke, F; Bunce, CM; di Maio, A; Drayson, MT; Francis, T; Jiang, Y; Khanim, FL; Radotra, A; Southam, AD; Trova, S1

Other Studies

8 other study(ies) available for valproic acid and medroxyprogesterone acetate

ArticleYear
Functional group contributions to drug-receptor interactions.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:12

    Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship

1984
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
A confusing case of confusion. Acute porphyrias.
    The Journal of the Oklahoma State Medical Association, 2008, Volume: 101, Issue:4

    Topics: Acidosis, Lactic; Acute Disease; Anticonvulsants; Brain; Confusion; Diagnosis, Differential; Diet, Reducing; Drug Combinations; Electroencephalography; Epilepsy, Tonic-Clonic; Estrogens, Conjugated (USP); Fatal Outcome; Female; Headache; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Middle Aged; Phenobarbital; Phenytoin; Porphyrias; Spinal Puncture; Tomography, X-Ray Computed; Valproic Acid; Vomiting; Weight Loss

2008
Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cells.
    Bioscience reports, 2021, 01-29, Volume: 41, Issue:1

    Topics: Bezafibrate; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Repositioning; Drug Therapy, Combination; Fatty Acid Synthases; Humans; Medroxyprogesterone Acetate; Mesenchymal Stem Cells; Osteosarcoma; Stearoyl-CoA Desaturase; Up-Regulation; Valproic Acid

2021
Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing.
    British journal of cancer, 2022, Volume: 126, Issue:2

    Topics: Anticonvulsants; Antioxidants; Bezafibrate; Cell Line, Tumor; Contraceptive Agents, Hormonal; Humans; Hypolipidemic Agents; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Medroxyprogesterone Acetate; NF-E2-Related Factor 2; Reactive Oxygen Species; Valproic Acid

2022